Cramer's 'Mad Money' Recap: Rite Aid Goes Wrong

For one, Goldman's prime brokerage business outshines the other players. Second, it's the only bank that seems to offer its clients real stability, he said. Goldman is the only finance stock that's doing well, while all the other banks are plagued with problems.

Goldman is a buy, Cramer said.

Healthy Medco

Cramer asked Medco Health (MHS Quote) CEO David Snow if he's being too aggressive in recommending the company.

Absolutely not, Snow said. Medco is very focused on improving its clinical outcomes, he said. It builds therapeutic resource centers and makes sure its physicians are specialized.

Further, Medco Health can tell patients if a certain drug might be better for a specific illness, Snow continued. This generates not only better generic dispensing rates for the company, but also boosts profitability.

Moreover, if UnitedHealth (UNH Quote) were to leave the company, Snow said he's made it very clear to investors that Medco Health would not change its guidance.

"This is an easy call for me," Cramer said. Medco Health is a high-visibility company that is not dependent on whether or not the Fed gets it right. It is a buy, he said.

Lightning Round

Cramer was bullish on Synchronoss Technologies (SNCR Quote), Monsanto (MON Quote), DuPont (DD Quote),

Accenture (ACN Quote), Harris (HRS Quote), Yamana Gold (AUY Quote) and eBay (EBAY Quote).